首页> 外国专利> METHOD OF TREATING MULTI-SPLINTERED AND MULTIPLE FRACTURES OF LONG TUBULAR BONES

METHOD OF TREATING MULTI-SPLINTERED AND MULTIPLE FRACTURES OF LONG TUBULAR BONES

机译:治疗长管状骨多裂多裂的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to traumatology and orthopedics, and is intended for treatment of multi-splintered and multiple fractures of long tubular bones. Reposition of bone fragments and their fixation by means of bone or intramedullary osteosynthesis are carried out. On 10-16 day after operation into fracture zone additionally autologic mesenchymal stem cells are introduced by injection in autologic serum in amount 25-50 mln cells, injection being made at following indices of clinical blood test: leucocytes 4-10*109/l, ESR - 2-20 mm/hour, stab neutrophils - 1-8%. Autologic mesenchymal stem cells are population of live 87-99.9% homogeneous on cell markers CD 34-; CD 45-; CD 44+; CD 90+; CD 105+; CD 106+ cells, isolated from patient's bone marrow and accumulated in vitro.;EFFECT: method ensures creation of optimal conditions for reparative osteogenesis, stimulation of reparative osteogenesis processes at early stages of compound fracture treatment and prevention of delayed union and formation of false joints, reduction of traumaticity.;2 dwg, 2 ex, 2 cl, 1 tbl
机译:技术领域本发明涉及医学,即涉及创伤学和骨科,并且用于治疗长管状骨的多裂和多裂骨折。骨碎片的重新定位及其通过骨或髓内骨合成的固定。手术后10到16天,进入骨折区,再通过注射25至50百万个细胞的自体血清,注入自体间充质干细胞,并按以下临床验血指标进行注射:白细胞4-10 * 10 9 / l,ESR-2-20毫米/小时,中性粒细胞刺伤-1-8%。自体间充质干细胞在细胞标记CD 34-上具有87-99.9%的均质活种群。 CD 45-; CD 44+; CD 90+; CD 105+; CD 106+细胞,从患者的骨髓中分离并在体外积累;效果:该方法可确保为修复性骨生成创造最佳条件,在复合骨折治疗的早期刺激修复性骨生成过程,并防止延迟愈合和假关节形成,减少创伤。; 2 dwg,2 ex,2 cl,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号